Location: Home
  • search
  • go
  • Relate News
  • 6/14/2022FDA's Treatment of China-Developed Drugs Spurs Demands for Multiregion...
  • 6/10/2022Delisting Risk, Souring Relations Are Hurdles for Chinese Biotech Firm...
  • 6/10/2022NHC and SATCM Issue the Rules for Internet Diagnosis and Treatment Reg...
  • 6/9/2022OnCusp and Multitude Enter into an Ex-China Licensing Agreement for a ...
  • 6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...
  • 6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021
  • 6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031
  • 6/7/2022Fosun Pharma Acquires 60% of Singapore OncoCare Medical for $158M
  • 6/7/2022China Issues the Notice on Correction of Irregularities in Drug Procur...
  • 6/7/2022How Shanghai Kept Clinical Trials Going During Lockdown (PharmaDJ)
  • 6/6/2022Pfizer/CStone Cejemly Gets China Approval for Expanded Use in Advanced...
  • 6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...
  • 6/6/2022China Issues the 14th Five-Year National Health Plan with A New Focus ...
  • 6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification
  • 6/3/2022Patient Activeness During Online Medical Consultation in China: Multil...
  • 6/2/2022NMPA Solicits Comments on the Draft Good Manufacturing Practices for D...
  • 6/2/2022China to Initiate Nationwide Unannounced BMI Fund Inspection
  • 6/2/2022Zelixir Biotech Looks to Help Global Monkeypox Drug Development
  • 6/1/2022Xuanzhu and CTTQ-Akeso Tie Up to Develop Penpulimab for Solid Tumors
  • 5/31/2022Recent Executive Moves
  • 5/30/2022SMEI: Review of Chinese Retail Pharmacy Market (Offline and Online)
  • 5/27/2022NMPA Issues Chinese GMP's Clinical Trial Drug Appendix
  • 5/26/2022Henlius and Abbott Enter Semi-Exclusive License Deal for Rituximab and...
  • 5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021
  • 5/26/2022April Licensing Trends Show Chinese Biotechs Expanding Beyond Oncology...
  • 5/26/2022Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)
  • 5/25/2022Hanmi Launches High-blood Pressure Drug Meiyaping (Amosartan) in China
  • 5/25/2022State Council Issues Notice on Major Tasks for Deepening Healthcare Re...
  • 5/24/2022Vir and WuXi Bio Terminate COVID Antibody Agreement
  • 5/24/2022ImaginAb and Yantai DongCheng Enter License Deal to Commercialize CD8...
  • Page:76/367 Total number of articles:10986: [First][<<] [74] [75] [76] [77] [78] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group